Product Name: BTBD9 Antibody
Species Reactivity: Human
Tested Applications: Flow, IHC-P, WB
Applications: For WB starting dilution is: 1:1000For IHC-P starting dilution is: 1:50~100For FACS starting dilution is: 1:10~50
User Note: Optimal dilutions for each application to be determined by the researcher.
Predicted Molecular Weight: 69 kDa
Immunogen: This BTBD9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 237-262 amino acids from the Central region of human BTBD9.
Host Species: Rabbit
Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.
Physical State: Liquid
CAS NO.: 132-60-5
Product: Cinchophen
Buffer: Supplied in PBS with 0.09% (W/V) sodium azide.
Concentration: 0.5 mg/ml
Storage Conditions: Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Clonality: Polyclonal
Conjugate: Unconjugated
Alternate Names: BTB/POZ domain-containing protein 9, BTBD9, KIAA1880
Accession NO.: Q96Q07
Protein Ino: 34395545
Official Symbol: BTBD9
Geneid: 114781
Background: This locus encodes a BTB/POZ domain-containing protein.This domain is known to be involved in protein-proteininteractions. Polymorphisms at this locus have been reported to beassociated with susceptibility to Restless Legs Syndrome and mayalso be associated with Tourette Syndrome.
PubMed ID:http://aac.asm.org/content/42/6/1336.abstract
